Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Sep 29, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹9.472-0.08% 1 day change | -6.02% | App exclusive | ₹331 Cr |
AUM (Fund size) | ₹331 Cr |
Exit load | 1.0% 1% for redemption within 3 Months! |
Lock-in Period | Nil |
Age | 9 m since Dec 06, 2024 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP: ₹1000 & Lumpsum: ₹5000 |
Expense ratio | 2.38% as on Aug 31, 2025 |
Plan type | Regular |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Period | This fund | Category average |
---|---|---|
1 Month | -2.03% | -1.58% |
3 Months | -2.28% | -2.06% |
6 Months | 4.33% | 4.18% |
Large Cap 40.26%
Mid Cap 20.7%
Small Cap 34.68%
Other Cap 0%
Healthcare 83.70999999999998%
Consumer Staples 7.789999999999999%
Services 2.0700000000000003%
Materials 1.67%
Bifurcation by Credit Quality is not available for this fund
Others 2.01%
Net Receivables 2.35%
CBLO 2.01%
Others 2.35%
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
Bajaj Finserv Healthcare Fund | -2.03% | 4.33% | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | -1.59% | 7.82% | 0.05% | 26.79% | 19.52% | 14.7% |
SBI Healthcare Opportunities Fund | -1.82% | 2.09% | 0.02% | 24.46% | 18.75% | 10.81% |
DSP Healthcare Fund | -1.82% | 2.44% | -6.15% | 22.13% | 16.86% | 14.31% |
Tata India Pharma & Healthcare Fund | -1.38% | 4.72% | -3.75% | 21.66% | 17.13% | 11.57% |
Mirae Asset Healthcare Fund | -0.99% | 3.4% | -3.37% | 19.92% | 16.8% | 14.21% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
Bajaj Finserv Healthcare Fund | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.51 | 0.94 | 1.27 | 1.79 |
SBI Healthcare Opportunities Fund | 13.91 | 0.84 | 1.29 | 1.93 |
DSP Healthcare Fund | 14.57 | 0.84 | 1.14 | 1.87 |
Tata India Pharma & Healthcare Fund | 15.94 | 0.97 | 1.0 | 1.54 |
Mirae Asset Healthcare Fund | 16.36 | 1.0 | 0.86 | 1.36 |
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
Bajaj Finserv Healthcare Fund | N.A. | 331 Cr | 9 m | 2.38% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 6,162 Cr | 7 yrs 3 m | 1.88% |
SBI Healthcare Opportunities Fund | N.A. | 3,963 Cr | 26 yrs 3 m | 1.93% |
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 10 m | 1.93% |
Tata India Pharma & Healthcare Fund | N.A. | 1,232 Cr | 9 yrs 9 m | 2.1% |
Mirae Asset Healthcare Fund | N.A. | 2,796 Cr | 7 yrs 3 m | 1.93% |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
Fund AUM | 331 Cr as on Aug 31, 2025 |
Scheme document | View Scheme Document |
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
No. of schemes | 15 view all schemes |
Total AUM | 24,110 Cr as on Jun 30, 2025 |
Address | S. No - 239/2, 11th Floor, Office No. 1101 A and 1101 B, Sky One Corporate Park, Lohegaon, Pune, Maharashtra Pune , 411032 |
Fund name | ETM Rank | AUM | 1Y | 5Y |
---|---|---|---|---|
Bajaj Finserv Flexi Cap Fund | N.A. | 5,410 Cr | -2.49% | N.A. |
Bajaj Finserv ELSS Tax Saver Fund | N.A. | 62 Cr | N.A. | N.A. |
Bajaj Finserv Large Cap Fund | N.A. | 1,592 Cr | -5.98% | N.A. |
Bajaj Finserv Consumption Fund | N.A. | 617 Cr | N.A. | N.A. |
The current Net Asset Value (NAV) of the Bajaj Finserv Healthcare Fund plan is approximately ₹9.472 as of Sep 29, 2025.
The Bajaj Finserv Healthcare Fund has an expense ratio of 2.38%, representing the annual cost of managing and operating the fund. This fee is deducted from the fund's AUM while declaring the daily NAV, reducing investor returns.
The Bajaj Finserv Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 331 Cr as on Aug 31, 2025.
The Bajaj Finserv Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Divi's Laboratories Ltd. | 7.86% |
Sun Pharmaceutical Industries Ltd. | 7.21% |
Apollo Hospitals Enterprise Ltd. | 6.29% |
Cipla Ltd. | 5.61% |
Fortis Healthcare Ltd. | 3.51% |
Emcure Pharmaceuticals Ltd. | 3.45% |
Biocon Ltd. | 3.45% |
Dr. Reddy's Laboratories Ltd. | 3.44% |
Dr. Lal Pathlabs Ltd. | 3.34% |
Neuland Laboratories Ltd. | 3.25% |
The Bajaj Finserv Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 83.70999999999998% |
Consumer Staples | 7.789999999999999% |
Services | 2.0700000000000003% |
Materials | 1.67% |
Chemicals | 0.4% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
Redeeming your investments in the Bajaj Finserv Healthcare Fund is simple. If you have invested via ET Money, just log in to the app, go to the holdings section, and submit the redemption request.
If you have invested from anywhere else, you can go to the fund house website and put a request through it.